Cargando…
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
Worldwide, an estimated 200 million people have chronic kidney disease (CKD), the most common causes of which include hypertension, arteriosclerosis, and diabetes. Importantly, ~40% of patients with diabetes develop CKD, yet evidence from major multicenter randomized controlled trials shows that int...
Autores principales: | Davies, Melanie, Chatterjee, Sudesna, Khunti, Kamlesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922775/ https://www.ncbi.nlm.nih.gov/pubmed/27382338 http://dx.doi.org/10.2147/CPAA.S82008 |
Ejemplares similares
-
Neuropathic pain; what we know and what we should do about it
por: Smith, Peter A.
Publicado: (2023) -
Commentary: What we should know about our learners
por: Groth, Shawn S., et al.
Publicado: (2020) -
What All We Should Know About Masks in COVID-19 Pandemic
por: Agrawal, Himanshu, et al.
Publicado: (2020) -
What do we know about pediatric renal microlithiasis?
por: Fallahzadeh, Mohammad Amin, et al.
Publicado: (2016) -
What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014)